BiotechTube
Home/Ipca Laboratories/Anand R. Desai
AR

Anand R. Desai

Whole-time Director

Ipca Laboratories

Therapeutic Areas

Anti-malarialsPain Management (NSAIDs)CardiovascularAnti-diabeticsAnti-infectivesGastrointestinalCNSDermatology

Ipca Laboratories Pipeline

DrugIndicationPhase
ANDA Portfolio (Generic Drugs)Various (Cardiovascular, CNS, Anti-infectives)Approved / Filed
Zerodol range (Aceclofenac)Pain & InflammationCommercial
Hydroxychloroquine SulfateMalaria, Lupus, Rheumatoid ArthritisCommercial
Chloroquine PhosphateMalariaCommercial
Metformin & CombinationsType 2 DiabetesCommercial
Cefixime & Ofloxacin combinationsBacterial InfectionsCommercial
Biosimilar (Rituximab)Oncology, Autoimmune DiseasesDevelopment
Biosimilar (Bevacizumab)OncologyDevelopment

Leadership Team at Ipca Laboratories

PG
Premchand Godha
Founder & Chairman Emeritus
AK
A. K. Jain
Managing Director
AK
Ajit Kumar Jain
Joint Managing Director
RC
R. C. Mehta
Whole-time Director
RV
R. V. Easwar
Independent Director
D(
Dr. (Mrs.) S. A. Nirmal
Independent Director
NH
N. H. Atthreya
Independent Director
RA
R. A. Shah
Independent Director
RK
R. K. Jain
Chief Financial Officer
AK
Atul K. Shah
President, International Business
View full Ipca Laboratories profile